208 related articles for article (PubMed ID: 26578881)
1. The prion protein constitutively controls neuronal store-operated Ca(2+) entry through Fyn kinase.
De Mario A; Castellani A; Peggion C; Massimino ML; Lim D; Hill AF; Sorgato MC; Bertoli A
Front Cell Neurosci; 2015; 9():416. PubMed ID: 26578881
[TBL] [Abstract][Full Text] [Related]
2. The Link of the Prion Protein with Ca
De Mario A; Peggion C; Massimino ML; Norante RP; Zulian A; Bertoli A; Sorgato MC
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546771
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons.
Um JW; Nygaard HB; Heiss JK; Kostylev MA; Stagi M; Vortmeyer A; Wisniewski T; Gunther EC; Strittmatter SM
Nat Neurosci; 2012 Sep; 15(9):1227-35. PubMed ID: 22820466
[TBL] [Abstract][Full Text] [Related]
4. Peptide aptamer targeting Aβ-PrP-Fyn axis reduces Alzheimer's disease pathologies in 5XFAD transgenic mouse model.
Ali T; Klein AN; Vu A; Arifin MI; Hannaoui S; Gilch S
Cell Mol Life Sci; 2023 May; 80(6):139. PubMed ID: 37149826
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's amyloid-β oligomers rescue cellular prion protein induced tau reduction via the Fyn pathway.
Chen RJ; Chang WW; Lin YC; Cheng PL; Chen YR
ACS Chem Neurosci; 2013 Sep; 4(9):1287-96. PubMed ID: 23805846
[TBL] [Abstract][Full Text] [Related]
6. Cellular prion protein is implicated in the regulation of local Ca2+ movements in cerebellar granule neurons.
Lazzari C; Peggion C; Stella R; Massimino ML; Lim D; Bertoli A; Sorgato MC
J Neurochem; 2011 Mar; 116(5):881-90. PubMed ID: 21214552
[TBL] [Abstract][Full Text] [Related]
7. The prion protein regulates glutamate-mediated Ca
De Mario A; Peggion C; Massimino ML; Viviani F; Castellani A; Giacomello M; Lim D; Bertoli A; Sorgato MC
J Cell Sci; 2017 Aug; 130(16):2736-2746. PubMed ID: 28701513
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease and prion protein.
Zhou J; Liu B
Intractable Rare Dis Res; 2013 May; 2(2):35-44. PubMed ID: 25343100
[TBL] [Abstract][Full Text] [Related]
9. Prion protein-mediated toxicity of amyloid-β oligomers requires lipid rafts and the transmembrane LRP1.
Rushworth JV; Griffiths HH; Watt NT; Hooper NM
J Biol Chem; 2013 Mar; 288(13):8935-51. PubMed ID: 23386614
[TBL] [Abstract][Full Text] [Related]
10. Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein.
Um JW; Kaufman AC; Kostylev M; Heiss JK; Stagi M; Takahashi H; Kerrisk ME; Vortmeyer A; Wisniewski T; Koleske AJ; Gunther EC; Nygaard HB; Strittmatter SM
Neuron; 2013 Sep; 79(5):887-902. PubMed ID: 24012003
[TBL] [Abstract][Full Text] [Related]
11. Binding between Prion Protein and Aβ Oligomers Contributes to the Pathogenesis of Alzheimer's Disease.
Kong C; Xie H; Gao Z; Shao M; Li H; Shi R; Cai L; Gao S; Sun T; Li C
Virol Sin; 2019 Oct; 34(5):475-488. PubMed ID: 31093882
[TBL] [Abstract][Full Text] [Related]
12. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
[TBL] [Abstract][Full Text] [Related]
13. Neuronal pathophysiology featuring PrP
Bertoli A; Sorgato MC
Prion; 2018 Jan; 12(1):28-33. PubMed ID: 29227178
[TBL] [Abstract][Full Text] [Related]
14. Activation of zebrafish Src family kinases by the prion protein is an amyloid-β-sensitive signal that prevents the endocytosis and degradation of E-cadherin/β-catenin complexes in vivo.
Sempou E; Biasini E; Pinzón-Olejua A; Harris DA; Málaga-Trillo E
Mol Neurodegener; 2016 Feb; 11():18. PubMed ID: 26860872
[TBL] [Abstract][Full Text] [Related]
15. Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease.
Scott-McKean JJ; Surewicz K; Choi JK; Ruffin VA; Salameh AI; Nieznanski K; Costa ACS; Surewicz WK
Neurobiol Dis; 2016 Jul; 91():124-131. PubMed ID: 26949218
[TBL] [Abstract][Full Text] [Related]
16. Amyloid-β induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease.
Um JW; Strittmatter SM
Prion; 2013; 7(1):37-41. PubMed ID: 22987042
[TBL] [Abstract][Full Text] [Related]
17. The anti-prion RNA aptamer R12 disrupts the Alzheimer's disease-related complex between prion and amyloid β.
Iida M; Mashima T; Yamaoki Y; So M; Nagata T; Katahira M
FEBS J; 2019 Jun; 286(12):2355-2365. PubMed ID: 30916478
[TBL] [Abstract][Full Text] [Related]
18. Targeting Fyn Kinase in Alzheimer's Disease.
Nygaard HB
Biol Psychiatry; 2018 Feb; 83(4):369-376. PubMed ID: 28709498
[TBL] [Abstract][Full Text] [Related]
19. Titanium dioxide and carbon black nanoparticles disrupt neuronal homeostasis via excessive activation of cellular prion protein signaling.
Ribeiro LW; Pietri M; Ardila-Osorio H; Baudry A; Boudet-Devaud F; Bizingre C; Arellano-Anaya ZE; Haeberlé AM; Gadot N; Boland S; Devineau S; Bailly Y; Kellermann O; Bencsik A; Schneider B
Part Fibre Toxicol; 2022 Jul; 19(1):48. PubMed ID: 35840975
[TBL] [Abstract][Full Text] [Related]
20. PrP(C) signalling in neurons: from basics to clinical challenges.
Hirsch TZ; Hernandez-Rapp J; Martin-Lannerée S; Launay JM; Mouillet-Richard S
Biochimie; 2014 Sep; 104():2-11. PubMed ID: 24952348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
